Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor

Illumina

09/04/2024 21:18

April 9 (Reuters) - Illumina  ILMN.O  said on Tuesday
Chief Financial Officer Joydeep Goswami would leave the gene
sequencing company and would be succeeded by Summit
Therapeutics'  SMMT.O  executive Ankur Dhingra.

 (Reporting by Pritam Biswas in Bengaluru; Editing by Shilpi
Majumdar)
 ((Pritam.Biswas@thomsonreuters.com;))